Sun Pharma’s arm acquires 11.86% stake in PJSC Biosintez

13 Mar 2019 Evaluate

Sun Pharmaceutical Industries’ wholly owned subsidiary -- Sun Pharma (Netherlands) BV has increased its shareholding in PJSC Biosintez, Russia, by way of purchase of 33958 shares equivalent to 11.86% of PJSC Biosintez under Mandatory Tender Offer.

Post the aforesaid purchase, the total holding of Sun Pharma (Netherlands) BV was increased from 85.10% to 96.96% in PJSC Biosintez.

Sun Pharmaceutical Industries is the world’s fourth largest specialty generic pharmaceutical company and India’s top pharmaceutical company.

Sun Pharma Inds. Share Price

1797.05 -7.90 (-0.44%)
08-Dec-2025 11:18 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.05
Dr. Reddys Lab 1275.15
Cipla 1511.05
Zydus Lifesciences 932.30
Lupin 2089.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×